Company profile PACB

Pacific Biosciences of California Inc
pacbio develops comprehensive solutions for scientists that propel the field of genomics, improve science and research, and create positive impact globally. we provide sophisticated genomic analysis systems that deliver invaluable insights for scientists who strive to resolve complex genetic challenges. our strength comes from the dedication of our people, who are fueled by a d...esire to effect real, positive change. with a focus on the future and an experienced, passionate team, we are motivated to continue to redefine what is possible in genomics. Show More
Quarter analysis & expected interestLast update: February 09 2024 01:31:48.

After 39 days of this quarter the interest is at 205.0. Based on that we can calculate that during remaining 52 days it will total up to 478.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019167
227
35.9% QoQ
239
5.3% QoQ
266
11.3% QoQ
2020 314
88.0% YoY 18.0% QoQ
213
-6.2% YoY -32.2% QoQ
278
16.3% YoY 30.5% QoQ
212
-20.3% YoY -23.7% QoQ
2021 217
-30.9% YoY 2.4% QoQ
233
9.4% YoY 7.4% QoQ
491
76.6% YoY 110.7% QoQ
234
10.4% YoY -52.3% QoQ
2022 445
105.1% YoY 90.2% QoQ
355
52.4% YoY -20.2% QoQ
375
-23.6% YoY 5.6% QoQ
386
65.0% YoY 2.9% QoQ
2023 401
-9.9% YoY 3.9% QoQ
429
20.8% YoY 7.0% QoQ
361
-3.7% YoY -15.9% QoQ
483
25.1% YoY 33.8% QoQ
2024 205
-48.9% YoY -57.6% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and pacbio sequencing search interestLast update: February 09 2024 01:31:47.
Correlation coefficient between keyword and revenue is 0.57
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 01:31:50.

The average 5 years interest of pacbio sequencing was 25.02 per week.
The last year interest of pacbio sequencing compared to the last 5 years has changed by 28.66%.
The interest for pacbio sequencing is trending.
The last year interest is quite higher compared to 5 years ago. It has increased by 66.18%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for PACB
Company name: Pacific Biosciences of California Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-11T13:46:35Z

Analyst Upgrades
Barclays Maintains Underweight on Pacific Biosciences, Raises Price Target to $1.5

2026-05-11T13:05:00Z

GlobeNewswire
HiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Using HiFi Long-Read Sequencing to Investigate Unexplained Subfertility and Recurrent Pregnancy Loss

2026-05-07T20:05:00Z

GlobeNewswire
PacBio Announces First Quarter 2026 Financial Results

2026-04-21T13:05:00Z

GlobeNewswire
PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing

2026-04-16T20:05:00Z

GlobeNewswire
PacBio to Report First Quarter 2026 Financial Results on May 7, 2026

2026-04-15T13:05:00Z

GlobeNewswire
PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples

2026-03-06T14:04:09Z

Analyst Upgrades
Barclays Downgrades Pacific Biosciences to Underweight, Lowers Price Target to $1.5

2026-03-05T13:30:00Z

GlobeNewswire
PacBio Announces the Appointment of Chris Gibson to the Board of Directors

2026-02-24T14:05:00Z

GlobeNewswire
PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research

2026-02-18T21:05:00Z

GlobeNewswire
PacBio to Participate in the TD Cowen 46th Annual Health Care Conference

2026-02-12T21:05:00Z

GlobeNewswire
PacBio Announces Fourth Quarter and Full Year 2025 Financial Results

2026-02-12T12:00:00Z

GlobeNewswire
PacBio Joins iHope Initiative as First Long-Read Genomic Sequencing Partner

2026-02-02T14:05:00Z

GlobeNewswire
PacBio Completes Sale of Short-Read Sequencing Assets

2026-01-27T21:05:00Z

GlobeNewswire
PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026

2026-01-12T14:15:00Z

GlobeNewswire
PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases